SeekingAlpha · Sep 28, 2026
Palatin Technologies, Inc. (PTN) Q4 2026 Earnings Call Transcript
Palatin Technologies, Inc. (PTN) Q4 2026 Earnings Call September 28, 2026 11:00 AM EDTCompany ParticipantsCarl Spana - Co-Founder, President, CEO &...
PT
AMEX · PTN
Palatin Technologies, Inc.
Healthcare · Biotechnology
$9.48
Up+$0.38 (+4.01%)
Updated Oct 6, 2026, 7:13 PM
SID Score
4.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 641.56M
- P/E ratio
- -4.99
- Dividend yield
- 0.00%
- 52-week range
- $7.21 – $23.78
- Volume
- 13.01K
- Avg. volume
- 1.78M
Price performance · PTN
PTN price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 5, 2026
PTN closed at $9.48 after 20 trading sessions, down 25.24% for the selected period.
- Last close
- $9.48
- Period change
- -25.24%
- Period low
- $8.87
- Period high
- $13.36
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 5, 2026 | $9.23 | $9.70 | $8.96 | $9.48 | 13.01K |
| Oct 2, 2026 | $9.02 | $9.45 | $8.6746 | $9.33 | 17.29K |
| Oct 1, 2026 | $8.74 | $9.12 | $8.68 | $9.06 | 33.05K |
| Sep 30, 2026 | $9.58 | $9.79 | $8.87 | $8.87 | 21.52K |
| Sep 29, 2026 | $9.54 | $9.69 | $9.04 | $9.12 | 32.88K |
| Sep 28, 2026 | $9.86 | $10.09 | $8.725 | $9.58 | 39.3K |
| Sep 25, 2026 | $9.85 | $10.35 | $9.50 | $10.095 | 22.38K |
| Sep 24, 2026 | $10.12 | $10.12 | $9.60 | $9.83 | 26.52K |
| Sep 23, 2026 | $10.79 | $10.79 | $9.81 | $10.27 | 41.21K |
| Sep 22, 2026 | $10.66 | $10.705 | $10.00 | $10.27 | 41.66K |
| Sep 21, 2026 | $11.03 | $11.73 | $10.22 | $10.22 | 57.78K |
| Sep 18, 2026 | $10.37 | $11.05 | $10.27 | $10.86 | 51.56K |
| Sep 17, 2026 | $9.51 | $10.64 | $9.50 | $10.43 | 34.2K |
| Sep 16, 2026 | $10.94 | $11.21 | $9.42 | $9.46 | 137.45K |
| Sep 15, 2026 | $13.07 | $13.37 | $10.77 | $10.94 | 147.64K |
| Sep 14, 2026 | $11.72 | $13.78 | $11.18 | $13.36 | 699.55K |
| Sep 11, 2026 | $11.82 | $12.57 | $11.40 | $11.80 | 20.61K |
| Sep 10, 2026 | $12.27 | $12.54 | $11.77 | $12.02 | 21.93K |
| Sep 9, 2026 | $12.28 | $12.87 | $11.7916 | $12.33 | 45.42K |
| Sep 8, 2026 | $12.62 | $13.33 | $11.77 | $12.68 | 138.09K |
Latest PTN news
The latest Smart Investors Daily articles mentioning PTN.
Stock researchCompany · Overview
Company
Market Activity
Research & News
PTN research
Overview
Company profile and research snapshot.
Company profile
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical needs and commercial potential. The Company's business is in one operating segment: life science.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $50.00
- Implied upside
- —
- Analysts
- 5
| Date | Firm | Rating | Target |
|---|---|---|---|
| Dec 12, 2025 | Laidlaw & Co. | Buy | — |
| Feb 13, 2025 | HC Wainwright & Co. | Buy | — |
| Feb 7, 2025 | HC Wainwright & Co. | Buy | — |
| Jan 29, 2025 | HC Wainwright & Co. | Buy | — |
| Jan 28, 2025 | HC Wainwright & Co. | Buy | — |
News briefing
No generated briefing is available yet.
Yahoo · Sep 28, 2026
Palatin Reports Fiscal Year 2026 Financial Results and Provides Business Update
Palatin Technologies, Inc. (Nasdaq: PTN), a biopharmaceutical company developing medicines that target the melanocortin receptor ("MCR") system, today reported financial results for the fiscal year ended June 30, 2026 and provided an update on its MC4R-focused obesity development programs and partnering activities.
Benzinga · Sep 28, 2026
Palatin Techs Q4 EPS $(1.11) Up From $(2.73) YoY, Sales $300.770K
Palatin Techs (NASDAQ:PTN) reported quarterly losses of $(1.11) per share. This is a 59.34 percent increase over losses of $(2.73) per share from the same period last year. The company reported $300.770 thousand in
SeekingAlpha · Feb 17, 2026
Palatin Technologies, Inc. (PTN) Q2 2026 Earnings Call Transcript
Palatin Technologies, Inc. (PTN) Q2 2026 Earnings Call February 17, 2026 11:00 AM ESTCompany ParticipantsCarl Spana - Co-Founder, President, CEO &...
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
